Evidence map›Paper›PMID 30686962›Full record

ArticleCase reports in gastroenterology

Adenosquamous Carcinoma of the Choledochus.

Daisuke Uehara, Hitoshi Takagi, Takashi Hoshino, Yuhei Suzuki, Satoshi Takakusagi, Kyoko Maruhashi, Kazuko Kizawa, Takashi Kosone, Atsushi Naganuma, Etsuko Hisanaga and 3 more

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Case reports in gastroenterology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 1 country.

Daisuke UeharaDepartment of Gastroenterology and Hepatology, Kusunoki Hospital, Fujioka, Japan.
Hitoshi TakagiDepartment of Gastroenterology and Hepatology, Kusunoki Hospital, Fujioka, Japan.
Takashi HoshinoDepartment of Gastroenterology and Hepatology, Takasaki General Medical Center, Takasaki, Japan.
Yuhei SuzukiDepartment of Gastroenterology and Hepatology, Kusunoki Hospital, Fujioka, Japan.
Satoshi TakakusagiDepartment of Gastroenterology and Hepatology, Kusunoki Hospital, Fujioka, Japan.
Kyoko MaruhashiDepartment of Gastroenterology and Hepatology, Kusunoki Hospital, Fujioka, Japan.
Kazuko KizawaDepartment of Gastroenterology and Hepatology, Kusunoki Hospital, Fujioka, Japan.
Takashi KosoneDepartment of Gastroenterology and Hepatology, Kusunoki Hospital, Fujioka, Japan.
Atsushi NaganumaDepartment of Gastroenterology and Hepatology, Takasaki General Medical Center, Takasaki, Japan.
Etsuko HisanagaDepartment of Pathology, Gunma University Hospital, Maebashi, Japan.
Junko HiratoDepartment of Pathology, Gunma University Hospital, Maebashi, Japan.
Satoru KakizakiDepartment of Gastroenterology and Hepatology, Gunma University Graduate School of Medicine, Maebashi, Japan.
Toshio UraokaDepartment of Gastroenterology and Hepatology, Gunma University Graduate School of Medicine, Maebashi, Japan.
Nippon Zoki (Japan) · JPGunma University · JPGunma University Hospital · JPNational Hospital Organization Takasaki Medical Center · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The patient was an 86-year-old man who was admitted with obstructive jaundice. Computed tomography revealed a tumor in the hilar choledochus with peripheral hepatic duct dilatation. Endoscopic cholangiography (ERC) demonstrated the defect in the choledochus. Brushing cytology during ERC showed Orange-G-philic keratinized atypical cells, which led to a diagnosis of squamous cell carcinoma. Chemotherapy with tegafur-gimeracil-oteracil potassium was ineffective and was discontinued due to adverse effects. The patient died 5 months after the diagnosis and autopsy revealed tubular adenocarcinoma of the hilar bile duct with squamous cell carcinoma component. Progression of the disease might influence the distribution of adenosquamous carcinoma. The clinicopathological sequence of adenosquamous carcinoma of the choledochus was documented.

Indexed as

Adenosquamous carcinomaCholedochus cancer

Identifiers

PMID30686962
PMCPMC6341349
OpenAlexW2907895903

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.